Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III study of SK08 live bacteria powder in diarrhea-predominant irritable bowel syndrome
ChiCTR2500103969Phase 3Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2025
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of SK08 in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Started Jun 2025; status: recruiting.
02
Drugs
SK08
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on ChiCTR2500103969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500103969.